Skip to main content
network of light circles and lines stretch across a dark blue background
BMB PhD Program Faculty

Anthony K.L. Leung

Targeting RNA regulation through poly(ADP-Ribose)

Professor

Department of Biochemistry and Molecular Biology
Bloomberg School of Public Health

Anthony Leung

Research Overview

My research program focuses on how gene regulation impacts diseases states including cancer, neurodegeneration and virus infection. Recent research focuses on a druggable protein modification called ADP-ribosylation. Poly(ADP-ribose) polymerase (PARP) inhibitors are currently approved by FDA to treat multiple cancers, while RNA viruses (e.g., coronavirus and alphaviruses) possess a conserved domain that removes ADP-ribosylation, which is critical for viral replication and virulence. We are now actively targeting this domain to develop novel antivirals. 

Though therapeutically important, ADP-ribosylation is understudied partly due to a woeful lack of tools. My team invents tools to investigate this protein modification, discovering its roles in various RNA processes, RNA virus infection, and the formation of biomolecular condensates. To dissect the underlying mechanisms, our team also use a range of multi-disciplinary techniques from chemical probe synthesis, single-molecule biophysical measurements and quantitative imaging to informatics, genomics and proteomics approaches. Our team is highly collaborative drawing expertise within the lab, the university and around the world. Our goal is to translate our multi-dimensional scientific findings to therapy and diagnostics.

 

 

Selected Publications